Annual Accounts Receivable
$38.30 M
+$14.83 M+63.15%
31 December 2023
Summary:
Castle Biosciences annual accounts receivable is currently $38.30 million, with the most recent change of +$14.83 million (+63.15%) on 31 December 2023. During the last 3 years, it has risen by +$25.54 million (+200.20%). CSTL annual accounts receivable is now at all-time high.CSTL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$50.26 M
+$4.27 M+9.29%
30 September 2024
Summary:
Castle Biosciences quarterly accounts receivable is currently $50.26 million, with the most recent change of +$4.27 million (+9.29%) on 30 September 2024. Over the past year, it has increased by +$13.26 million (+35.83%). CSTL quarterly accounts receivable is now at all-time high.CSTL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.1% | +35.8% |
| 3 y3 years | +200.2% | +171.2% |
| 5 y5 years | +216.8% | +306.3% |
CSTL Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +200.2% | at high | +190.8% |
| 5 y | 5 years | at high | +216.8% | at high | +306.3% |
| alltime | all time | at high | +723.3% | at high | +444.6% |
Castle Biosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $50.26 M(+9.3%) |
| June 2024 | - | $45.99 M(+7.7%) |
| Mar 2024 | - | $42.70 M(+11.5%) |
| Dec 2023 | $38.30 M(+63.2%) | $38.30 M(+3.5%) |
| Sept 2023 | - | $37.00 M(+18.2%) |
| June 2023 | - | $31.31 M(+12.9%) |
| Mar 2023 | - | $27.73 M(+18.1%) |
| Dec 2022 | $23.48 M(+35.8%) | $23.48 M(+2.8%) |
| Sept 2022 | - | $22.84 M(+1.0%) |
| June 2022 | - | $22.61 M(+13.5%) |
| Mar 2022 | - | $19.91 M(+15.2%) |
| Dec 2021 | $17.28 M | $17.28 M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $18.53 M(+4.0%) |
| June 2021 | - | $17.82 M(+24.7%) |
| Mar 2021 | - | $14.29 M(+12.0%) |
| Dec 2020 | $12.76 M(-12.9%) | $12.76 M(+1.1%) |
| Sept 2020 | - | $12.62 M(+0.7%) |
| June 2020 | - | $12.53 M(-14.2%) |
| Mar 2020 | - | $14.60 M(-0.3%) |
| Dec 2019 | $14.65 M(+21.2%) | $14.65 M(+18.4%) |
| Sept 2019 | - | $12.37 M(+27.1%) |
| June 2019 | - | $9.73 M(+5.4%) |
| Mar 2019 | - | $9.23 M(-23.7%) |
| Dec 2018 | $12.09 M(+159.9%) | $12.09 M |
| Dec 2017 | $4.65 M | - |
FAQ
- What is Castle Biosciences annual accounts receivable?
- What is the all time high annual accounts receivable for Castle Biosciences?
- What is Castle Biosciences annual accounts receivable year-on-year change?
- What is Castle Biosciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Castle Biosciences?
- What is Castle Biosciences quarterly accounts receivable year-on-year change?
What is Castle Biosciences annual accounts receivable?
The current annual accounts receivable of CSTL is $38.30 M
What is the all time high annual accounts receivable for Castle Biosciences?
Castle Biosciences all-time high annual accounts receivable is $38.30 M
What is Castle Biosciences annual accounts receivable year-on-year change?
Over the past year, CSTL annual accounts receivable has changed by +$14.83 M (+63.15%)
What is Castle Biosciences quarterly accounts receivable?
The current quarterly accounts receivable of CSTL is $50.26 M
What is the all time high quarterly accounts receivable for Castle Biosciences?
Castle Biosciences all-time high quarterly accounts receivable is $50.26 M
What is Castle Biosciences quarterly accounts receivable year-on-year change?
Over the past year, CSTL quarterly accounts receivable has changed by +$13.26 M (+35.83%)